Janssen Pharmaceutica NV

Janssen Pharmaceutica NV

Janssen Pharmaceutica NV

Overview
Date Founded

1934

Headquarters

Turnhoutseweg 30,Beerse, Flemish Region 2340

Type of Company

Private

Industries

Pharmaceuticals

Company Description

Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium.

Executives & Employees

Company Group Chairman, Europe, Middle East & Africa

Managing Director, Janssen BioTech & Head of General Research Coordination

Vice President-Regulatory Affairs

Vice President-Strategy & Business Improvement Management

Paths to Janssen Pharmaceutica NV
Potential Connections via
Relationship Science
You
Janssen Pharmaceutica NV
Recent Transactions
Details Hidden

Johnson & Johnson, Janssen Pharmaceutica NV purchase WeylChem GmbH /Pyrion Business from WeylChem International GmbH

Transaction Advisors
Legal Advisor

Advised onEli Lilly & Company, Elanco Animal Health, Inc. purchase Janssen Animal Health BVBA from Johnson & Johnson

Advisors & Consultants
Consultant

Chairman & Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at University of Texas - MD Anderson Cancer Center

Legal Advisor

Principal at Chuhak & Tecson PC

Non-Profit Donations & Grants Received
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Janssen Pharmaceutica NV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Janssen Pharmaceutica NV's profile does not indicate a business or promotional relationship of any kind between RelSci and Janssen Pharmaceutica NV.